The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Broadfoot Jill Marie since 2018.
This trader's CIK number is 1305178.
At the time of last reporting, Broadfoot Jill Marie was the Chief Financial Officer of Atyr Pharma Inc. (stock ticker symbol ATYR).
Also see all insider trading activities at Atyr Pharma Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | ATYR | 0 | $0 | 1,558 | $1,520 | 3,750 | $0 |
| 2025 | ATYR | 0 | $0 | 1,254 | $4,740 | 3,750 | $0 |
| 2024 | ATYR | 5,000 | $8,950 | 1,590 | $2,687 | 3,750 | $0 |
| 2023 | ATYR | 0 | $0 | 1,566 | $3,695 | 3,750 | $0 |
| 2022 | ATYR | 1,923 | $12,980 | 0 | $0 | 0 | $0 |
| 2021 | ATYR | 0 | $0 | 390 | $2,987 | 892 | $0 |
| 2020 | ATYR | 1,850 | $7,806 | 375 | $1,511 | 893 | $0 |
| 2018 | ATYR | 90,000 | $71,900 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-02-03 | ATYR | Option Ex | 3,750 | .00 | 0 |
| 2026-02-04 | ATYR | Sale | 1,558 | .98 | 1,520 |
| 2025-02-04 | ATYR | Sale | 1,254 | 3.78 | 4,740 |
| 2025-02-03 | ATYR | Option Ex | 3,750 | .00 | 0 |
| 2024-05-31 | LIFE | Buy | 5,000 | 1.79 | 8,950 |
| 2024-02-05 | LIFE | Option Ex | 3,750 | .00 | 0 |
| 2024-02-06 | LIFE | Sale | 1,590 | 1.69 | 2,687 |
| 2023-02-03 | LIFE | Option Ex | 3,750 | .00 | 0 |
| 2023-02-06 | LIFE | Sale | 1,566 | 2.36 | 3,695 |
| 2022-01-13 | LIFE | Buy | 1,923 | 6.75 | 12,980 |
| 2021-02-06 | LIFE | Option Ex | 892 | .00 | 0 |
| 2021-02-09 | LIFE | Sale | 390 | 7.66 | 2,987 |
| 2020-06-19 | LIFE | Buy | 1,850 | 4.22 | 7,806 |
| 2020-02-06 | LIFE | Option Ex | 893 | .00 | 0 |
| 2020-02-07 | LIFE | Sale | 375 | 4.03 | 1,511 |
| 2018-09-19 | LIFE | Buy | 26,000 | .81 | 21,112 |
| 2018-09-20 | LIFE | Buy | 38,000 | .83 | 31,730 |
| 2018-09-14 | LIFE | Buy | 26,000 | .73 | 19,058 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Broadfoot Jill Marie (Chief Financial Officer of Atyr Pharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.